Literature DB >> 12766612

Laboratory strategies for efficient handling of paraffin-embedded tissues for molecular detection of clonality in non-hodgkin lymphomas.

Claudio Gustavo Stefanoff1, Rocío Hassan, Ana Carolina Gonzalez, Luiz Antônio B Andrade, Daniel G Tabak, Sérgio Romano, Ilana R Zalcberg.   

Abstract

We herein present a technical strategy to optimize DNA isolation from paraffin-embedded tissue (PET). This includes the choice of adequate buffers for proteinase K digestion and multiplex PCR amplifications for assessing the appropriateness of DNA extracts for subsequent PCR assays for detecting clonality. We found that the association of proteinase K digestion in nonionic buffer and subsequent extract dilutions accounted for 79% of successful amplifications. A final efficiency of 88% was achieved by additional organic extractions and/or re-extractions. Comparisons were carried out with control DNA extracts from fresh samples to assess the efficiency of each clonality assay. Immunoglobulin CDRIII rearranged region amplification was more efficient for pregerminal center B-cell lymphomas in contrast to CDRII rearrangement detection, which was more effective for germinal and postgerminal lymphomas. T-cell clonality detection by TCRgamma PCR was less efficient in PET samples than in fresh tissues showing that DNA integrity is more critical for TCR than for IGH amplification. Two inconclusive cases without phenotypic markers and two other atypical lymphoproliferations masked by reactive T cells were diagnosed as plasmablastic lymphomas and as monoclonal B-proliferations, respectively, due to IGH rearrangements.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766612     DOI: 10.1097/00019606-200306000-00003

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  5 in total

1.  Application of BIOMED-2 primers in fixed and decalcified bone marrow biopsies: analysis of immunoglobulin H receptor rearrangements in B-cell non-Hodgkin's lymphomas.

Authors:  Silke Lassmann; Uirike V Gerlach; Katja Technau-Ihling; Martin Werner; Paul Fisch
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

2.  Identification of three novel RB1 mutations in Brazilian patients with retinoblastoma by "exon by exon" PCR mediated SSCP analysis.

Authors:  E Braggio; C R Bonvicino; F R Vargas; S Ferman; A L A Eisenberg; H N Seuánez
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

3.  Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma.

Authors:  Carolina Minnicelli; Mário H M Barros; Claudete E Klumb; Sérgio O Romano; Ilana R Zalcberg; Rocio Hassan
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

4.  Epstein-Barr virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma.

Authors:  Rocío Hassan; Lídia Roxana White; Claudio Gustavo Stefanoff; Deilson Elgui de Oliveira; Fabricio E Felisbino; Claudete Esteves Klumb; Carlos E Bacchi; Héctor N Seuánez; Ilana R Zalcberg
Journal:  Diagn Pathol       Date:  2006-08-07       Impact factor: 2.644

5.  Study of Epstein-Barr virus expression in Burkitt's lymphoma by polymerase chain reaction and in situ hybridization: A study in Iran.

Authors:  Parviz Deyhimi; Mahsa Kalantari
Journal:  Dent Res J (Isfahan)       Date:  2014-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.